Nano+™ Polymer-free Sirolimus-eluting Coronary Stent System

Nano+™ Polymer Free Drug Eluting Stents System
Nano+™
Nothing Beats Free

Nano+™ Polymer-free Sirolimus-eluting Coronary Stent System Details

Product Description
Nanoporous cavities on strut abluminal surface functioning as drug carrier to ensure the firm adhesion.

Vacuum drug coating technology ensures complete drug dosage and coating stability.

Post-treatment after drug loading helps with sustained drug release.

Soft tapered tip provides smooth transition from guidewire to balloon catheter and excellent crossability.

Short shoulder design at both ends of the balloon ensures the accurate dilation to the lesion, and reduces the damage to normal vessel next to the lesion.

Patented hydrophilic coating on distal shaft provides outstanding pushability.

Polymer-free design significantly reduces the inflammatory response after stent implantation to guarantee the long-term safety.

Polymer-free design facilitates earlier endothelialization which significantly shorten the DAPT time.

The rough strut surface helps with earlier and easier endothelialization to reduce the risk of thrombosis.

Prouduct Features
Polymer-free DES

Nanoporous drug carrier on abluminal surface

Balanced strut thickness

High radial force

Sine wave + 3-3-3 link

Double helix structure

Large open cell

Precise positioning markers

Effective drug of Sirolimus

Vacuum drug coating technology

90-day drug releasing period

New delivery system

Prouduct Benefits
Significantly shorten DAPT time

Earlier & better endothelialization

Highly reduced risk of thrombosis

Great deliverability

Easy positioning and placement

Optimal tissue scaffolding

Excellent side branch access

Scientific drug releasing period

Prouduct Ranges
Ø 2.5 - 4.0 mm

12 - 36 mm multi stent lengths

Clinical Studies
An OCT Study in Europe Shows Nano+™ A Great Combination of DES Efficacy and BMS Safety [3].

In a prospective, multicentre, single-arm, open-label study, OCT examinations

were performed at three months in 45 patients (47 lesions). 23 patients with 24 lesions

had serial coronary angiography and OCT assessment at three and six months.

Coverage status of the individual stents/patients at two time points (three and six months).

Serial OCT showed almost complete vascular healing at six months, even when coverage was insufficient at three months. This suggests an adequate safety and efficacy profile of the device at that point in time.

*Product registration and availability vary by country. For more information on product availability, please contact us here.

Specifications
Technical Parameters
Stent Material 316L Stainless Steel
Strut Design Nanoporous drug carrier on abluminal surface
Metal to Artery Ratio 15%
Recoil < 2%
Shortening < 1%
Crossing Profile 0.035″(0.90mm)

*Product registration and availability vary by country. For more information on product availability, please contact us here.

Ordering Information
Stent Diameter Stent Length (mm)
(mm) 12 15 18 21 24 29 33 36
2.5 LPRPS2512 LPRPS2515 LPRPS2518 LPRPS2521 LPRPS2524 LPRPS2529 LPRPS2533 -
2.75 LPRPS2712 LPRPS2715 LPRPS2718 LPRPS2721 LPRPS2724 LPRPS2729 LPRPS2733 LPRPS2736
3 LPRPS3012 LPRPS3015 LPRPS3018 LPRPS3021 LPRPS3024 LPRPS3029 LPRPS3033 LPRPS3036
3.5 LPRPS3512 LPRPS3515 LPRPS3518 LPRPS3521 LPRPS3524 LPRPS3529 LPRPS3533 LPRPS3536
4 LPRPS4012 LPRPS4015 LPRPS4018 LPRPS4021 LPRPS4024 LPRPS4029 LPRPS4033 LPRPS4036

As one of cardiovascular products manufacturers, we can provide kinds of medical devices china for sale, if you have needs, please contact us.